Fundraising Fox

Scott Gottlieb

Investor

Special Partner at New Enterprise Associates (NEA)

Chevy Chase, Maryland

Writes $2M – $50M checks · typically $25M

About

Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Experience

  1. New Enterprise AssociatesPartnercurrent2007 — presentChevy Chase, MD
  2. American Enterprise InstituteSenior Fellowcurrent2003 — presentWashington D.C. Metro Area
  3. National Academy of MedicineElected Membercurrent2018 — presentWashington D.C. Metro Area
  4. PfizerIndependent Member of the Board of Directorscurrent2019 — presentBoston, MA
  5. UnitedHealth GroupIndependent Member of the Board of Directorscurrent2025 — presentMinnesota, United States
  6. IlluminaChairman of the Board of Directorscurrent2020 — presentSan Diego, California, United States
  7. Xaira TherapeuticsBoard Membercurrent2024 — presentSan Francisco, California, United States
  8. Comanche BiopharmaBoard Membercurrent2024 — presentBoston, Massachusetts, United States
  9. ResilienceBoard Membercurrent2020 — presentBoston, Massachusetts, United States
  10. AetionBoard Membercurrent2019 — presentNew York, United States
  11. Tempus AIIndependent Member of the Board of Directorscurrent2019 — presentChicago, Illinois, United States
  12. FDACommissioner2017 — 2019White Oak, MD
  13. U.S. Department of Health and Human Services (HHS)Member Federal Health IT Policy Committee2013 — 2017Washington, DC
  14. Society of Hospital MedicineMember of the Policy Board2011 — 2017
  15. Daiichi Sankyo, Inc.Independent Member of the Board of Directors2015 — 2017Livingston, NJ
  16. American Pathology PartnersIndependent Member of the Board of Directors2012 — 2017Denver, CO
  17. NYU Langone HealthClinical Assistant Professor2011 — 2017New York, NY
  18. GlaxoSmithKlineMember of the Product Investment Board2010 — 2017Greater Philadelphia Area
  19. Gradalis, Inc.Independent Member of the Board of Directors2015 — 2017Dallas, TX
  20. MedAvanteIndependent Member of the Board of Directors2007 — 2017Princeton, NJ
  21. Tolero Pharmaceuticals, Inc.Independent Member of the Board of Directors2015 — 2016Lehi, UT
  22. Aptiv SolutionsIndependent Member of the Board of Directors2012 — 2014Falls Church, VA
  23. The Leukemia & Lymphoma SocietyMember of the Policy Board2012 — 2014Washington, DC
  24. Bravo HealthIndependent Member of the Board of Directors2009 — 2011Baltimore, Maryland Area
  25. Molecular Insight PharmaceuticalsIndependent Member of the Board of Directors2007 — 2010Cambridge, MA
  26. FDADeputy Commissioner for Medical and Scientific Affairs2005 — 2007Rockville, MD
  27. FDASenior Adviser to the Commissioner and Director of Medical Policy Development2003 — 2004Rockville, MD
  28. Centers for Medicare & Medicaid ServicesSenior Adviser to the Administrator2004Washington D.C. Metro Area
  29. British Medical AssociationMedical Staff Writer, British Medical Journal1998 — 2003London, England
  30. Alex. Brown & Sons, Inc.Investment Banking Analyst1994 — 1995Baltimore, MD

Skills & more

Board LevelHealthcare Information Technology18Health Policy81Healthcare90Strategic Planning22Policy Analysis34Public Policy49Pharmaceutical Industry28Clinical Trials7Medicare6Entrepreneurship2Strategic Communications13
+12 moreNonprofitsStrategyPublic HealthPublic SpeakingCoalitionsResearchGovernmentLegislative RelationsPolicyPublic RelationsPoliticsMedicine

From Scott's professional profile.

Deals · 1

Tempus LabsBoard seat

via New Enterprise Associates (NEA) · filed Oct 2022 · $10M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at New Enterprise Associates (NEA)

Aaron Jacobson
Partner at New Enterprise Associates (NEA)
Alex Sharata
Partner at New Enterprise Associates (NEA)
Alexa Grabelle
Associate at New Enterprise Associates (NEA)
Ali Behbahani
Partner, Co-Head of Healthcare at New Enterprise Associates (NEA)
Andrew Schoen
Partner at New Enterprise Associates (NEA)
Ann Bordetsky
Partner at New Enterprise Associates (NEA)
Arjun Jain
Partner at New Enterprise Associates (NEA)
Aya Somai
Associate at New Enterprise Associates (NEA)

Frequently asked questions

Who is Scott Gottlieb?
Scott Gottlieb is a physician and policy expert who joined NEA's healthcare investment team as a Special Partner in 2019, having previously been a Venture Partner at the firm from 2007 to 2017. Between those roles he served as the 23rd Commissioner of the U.S. Food and Drug Administration (2017–2019), and earlier held positions as FDA Deputy Commissioner and Senior Adviser at the Centers for Medicare and Medicaid Services. He was a practicing hospitalist and Clinical Assistant Professor at NYU School of Medicine, is a graduate of Mount Sinai School of Medicine and Wesleyan University, and at NEA focuses on healthcare investing with an emphasis on biopharma and healthcare services.
Where does Scott Gottlieb work?
Scott Gottlieb is Special Partner at New Enterprise Associates (NEA).
What does Scott Gottlieb invest in?
Scott Gottlieb invests in AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
What check size does Scott Gottlieb write?
Scott Gottlieb typically writes checks of $2M – $50M.
What boards does Scott Gottlieb sit on?
Scott Gottlieb holds tracked board seats at Tempus Labs.
Where did Scott Gottlieb go to school?
Scott Gottlieb studied at Icahn School of Medicine at Mount Sinai (Resident, Internal Medicine Residency Program); Icahn School of Medicine at Mount Sinai (Doctor of Medicine (MD), Medicine); Wesleyan University (BA, Economics).

Same school

Also attended Icahn School of Medicine at Mount Sinai17

Justin RobenyAssociate at Osage University PartnersOmar Njie, MDPrincipal at AlleyCorpVinod MittaVenture Partner at Floating PointTara BishopInvestor at Black Opal VenturesSharon HuangAssociate at Tau VenturesSilke R. SperlingManaging Partner at Catalpa Ventures

+ 11 more

Also attended Wesleyan University62

Jennifer ZimmermanMarketing & Communications at General CatalystDan LynchInvestor at GV (Google Ventures)David SchenkeinInvestor at GV (Google Ventures)Andy WeissmanPartner at Union Square Ventures (USV)Brad BurnhamPartner at Union Square Ventures (USV)Kristen LaguerreExecutive Partner at MPM BioImpact

+ 56 more

Shared employers

Also worked at American Enterprise Institute6

Vince SollittoVenture Partner at Copper Sky CapitalJoseph FullerProfessor, Harvard Business School at Juvo VenturesRegan BradyAnalyst at Linse CapitalTomas PhilipsonManaging Partner at MEDA VenturesEmily McElroyTalent at Amplify PartnersAdish JainFounder at Mosaic

Also worked at National Academy of Medicine4

Seth GlickmanDigital Health Advisor at Excelerate Health VenturesFatima Cody StanfordVenture Advisor at Pier 70 VenturesTerry HuangInvestor at COREangelsRebekah E. Gee MD MPHFounder at Nest Health

Also worked at Xaira Therapeutics7

Konstantine BuhlerInvestor at Sequoia CapitalDusan PerovicPartner at Two Sigma VenturesVikram BajajAdvisor at Foresite CapitalUplaksh KumarVenture Partner at Foresite CapitalGreg YapPartner at Menlo VenturesRachel LanePrincipal at Versant Ventures

+ 1 more

Also worked at Tempus AI10

Steve MurrayAdvisor, Revolution Growth at RevolutionEric LefkofskyEntrepreneur & PhilanthropistNick OlsenPrincipal at Innovation EndeavorsJoel DudleyVenture Partner at Innovation EndeavorsKunaal PatelInvestor at Acrew CapitalJonathan OzeranAdvisor at Good Growth Capital

+ 4 more